AAAAAA
Results:
1-13
|
Results: 13
Authors:
Egg, R
Reindl, M
Deisenhammer, F
Linington, C
Berger, T
Citation: R. Egg et al., Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis, MULT SCLER, 7(5), 2001, pp. 285-289
Authors:
Deisenhammer, F
Reindl, M
Berger, T
Citation: F. Deisenhammer et al., Immunoglobulin subclasses in patients with neutralizing and nonneutralizing antibodies against TFN-beta 1b, J INTERF CY, 21(3), 2001, pp. 167-171
Authors:
Stefanova, N
Klimaschewski, L
Poewe, W
Wenning, GK
Reindl, M
Citation: N. Stefanova et al., Glial cell death induced by overexpression of alpha-synuclein, J NEUROSC R, 65(5), 2001, pp. 432-438
Authors:
Mayringer, I
Reindl, M
Pfausler, B
Berger, W
Berger, T
Schmutzhard, E
Citation: I. Mayringer et al., Are cytokines and adhesion molecules useful parameters to differentiate bacterial from fungal ventriculitis?, INTEN CAR M, 27(6), 2001, pp. 1097-1097
Authors:
Reindl, M
Knipping, G
Wicher, I
Dilitz, E
Egg, R
Deisenhammer, F
Berger, T
Citation: M. Reindl et al., Increased intrathecal production of apolipoprotein D in multiple sclerosis, J NEUROIMM, 119(2), 2001, pp. 327-332
Authors:
Haase, CG
Guggenmos, J
Brehm, U
Andersson, M
Olsson, T
Reindl, M
Schneidewind, JM
Zettl, UK
Heidenreich, F
Berger, T
Wekerle, H
Hohlfeld, R
Linington, C
Citation: Cg. Haase et al., The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls, J NEUROIMM, 114(1-2), 2001, pp. 220-225
Authors:
Fazekas, F
Strasser-Fuchs, S
Kollegger, H
Berger, T
Kristoferitsch, W
Schmidt, H
Enzinger, C
Schiefermeier, M
Schwarz, C
Kornek, B
Reindl, M
Huber, K
Grass, R
Wimmer, G
Vass, K
Pfeiffer, KH
Hartung, HP
Schmidt, R
Citation: F. Fazekas et al., Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis, NEUROLOGY, 57(5), 2001, pp. 853-857
Authors:
Beer, R
Franz, G
Schopf, M
Reindl, M
Zelger, B
Schmutzhard, E
Poewe, W
Kampfl, A
Citation: R. Beer et al., Expression of Fas and Fas ligand after experimental traumatic brain injuryin the rat, J CEREBR B, 20(4), 2000, pp. 669-677
Authors:
Deisenhammer, F
Mayringer, I
Harvey, J
Dilitz, E
Gasse, T
Stadlbauer, D
Reindl, M
Berger, T
Citation: F. Deisenhammer et al., A comparative study of the relative bioavailability of different interferon beta preparations, NEUROLOGY, 54(11), 2000, pp. 2055-2060
Authors:
Mayringer, I
Reindl, M
Berger, T
Citation: I. Mayringer et al., A critical comparison of frequently used methods for the analysis of tumornecrosis factor-alpha expression by human immune cells, J IMMUNOL M, 235(1-2), 2000, pp. 33-40
Authors:
Deisenhammer, F
Reindl, M
Harvey, J
Gasse, T
Dilitz, E
Berger, T
Citation: F. Deisenhammer et al., Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies, NEUROLOGY, 52(6), 1999, pp. 1239-1243
Authors:
Franz, G
Reindl, M
Patel, SC
Beer, R
Unterrichter, I
Berger, T
Schmutzhard, E
Poewe, W
Kampfl, A
Citation: G. Franz et al., Increased expression of apolipoprotein D following experimental traumatic brain injury, J NEUROCHEM, 73(4), 1999, pp. 1615-1625
Authors:
Reindl, M
Linington, C
Brehm, U
Egg, R
Dilitz, E
Deisenhammer, F
Poewe, W
Berger, T
Citation: M. Reindl et al., Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study, BRAIN, 122, 1999, pp. 2047-2056
Risultati:
1-13
|